Literature DB >> 33035329

Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations.

Simone Feurstein1, Ayodeji Adegunsoye2, Danijela Mojsilovic1, Rekha Vij2, Allison H West DePersia3, Padma Sheila Rajagopal1, Afaf Osman1, Robert H Collins4, Raymond H Kim5,6, Steven D Gore7, Peter Greenberg8, Lucy A Godley1, Zejuan Li9, Daniela Del Gaudio10, Hari Prasanna Subramanian10, Soma Das10, Tom Walsh11,12, Suleyman Gulsuner11,12, Jeremy P Segal13, Aliya N Husain13, Sandeep Gurbuxani13, Mary-Claire King11,12, Mary E Strek2, Jane E Churpek1.   

Abstract

Telomere biology disorders (TBDs) present heterogeneously, ranging from infantile bone marrow failure associated with very short telomeres to adult-onset interstitial lung disease (ILD) with normal telomere length. Yield of genetic testing and phenotypic spectra for TBDs caused by the expanding list of telomere genes in adults remain understudied. Thus, we screened adults aged ≥18 years with a personal and/or family history clustering hematologic disorders and/or ILD enrolled on The University of Chicago Inherited Hematologic Disorders Registry for causative variants in 13 TBD genes. Sixteen (10%) of 153 probands carried causative variants distributed among TERT (n = 6), TERC (n = 4), PARN (n = 5), or RTEL1 (n = 1), of which 19% were copy number variants. The highest yield (9 of 22 [41%]) was in families with mixed hematologic and ILD presentations, suggesting that ILD in hematology populations and hematologic abnormalities in ILD populations warrant TBD genetic testing. Four (3%) of 117 familial hematologic disorder families without ILD carried TBD variants, making TBD second to only DDX41 in frequency for genetic diagnoses in this population. Phenotypes of 17 carriers with heterozygous PARN variants included 4 (24%) with hematologic abnormalities, 67% with lymphocyte telomere lengths measured by flow cytometry and fluorescence in situ hybridization at or above the 10th percentile, and a high penetrance for ILD. Alternative etiologies for cytopenias and/or ILD such as autoimmune features were noted in multiple TBD families, emphasizing the need to maintain clinical suspicion for a TBD despite the presence of alternative explanations.
© 2020 by The American Society of Hematology.

Entities:  

Keywords:  NEOPLASIA/Myeloid leukemias and dysplasias; NEOPLASIA/myeloid leukemias and dysplasias: Genetic and other predisposing conditions; bone marrow failure; familial MDS/acute leukemia; telomere biology disorder

Mesh:

Substances:

Year:  2020        PMID: 33035329      PMCID: PMC7556157          DOI: 10.1182/bloodadvances.2020001721

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


  56 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia.

Authors:  Rodrigo T Calado; Joshua A Regal; Mark Hills; William T Yewdell; Leandro F Dalmazzo; Marco A Zago; Peter M Lansdorp; Donna Hogge; Stephen J Chanock; Elihu H Estey; Roberto P Falcão; Neal S Young
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-15       Impact factor: 11.205

3.  Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.

Authors:  Diane H Moon; Matthew Segal; Baris Boyraz; Eva Guinan; Inga Hofmann; Patrick Cahan; Albert K Tai; Suneet Agarwal
Journal:  Nat Genet       Date:  2015-10-19       Impact factor: 38.330

4.  Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.

Authors:  Siobán B Keel; Angela Scott; Marilyn Sanchez-Bonilla; Phoenix A Ho; Suleyman Gulsuner; Colin C Pritchard; Janis L Abkowitz; Mary-Claire King; Tom Walsh; Akiko Shimamura
Journal:  Haematologica       Date:  2016-07-14       Impact factor: 9.941

5.  Subclinical lung disease, macrocytosis, and premature graying in kindreds with telomerase (TERT) mutations.

Authors:  Alberto Diaz de Leon; Jennifer T Cronkhite; Cuneyt Yilmaz; Cecelia Brewington; Richard Wang; Chao Xing; Connie C W Hsia; Christine Kim Garcia
Journal:  Chest       Date:  2011-02-24       Impact factor: 9.410

6.  Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity.

Authors:  Michael Y Zhang; Siobán B Keel; Tom Walsh; Ming K Lee; Suleyman Gulsuner; Amanda C Watts; Colin C Pritchard; Stephen J Salipante; Michael R Jeng; Inga Hofmann; David A Williams; Mark D Fleming; Janis L Abkowitz; Mary-Claire King; Akiko Shimamura
Journal:  Haematologica       Date:  2014-09-19       Impact factor: 9.941

Review 7.  Survival after Hematopoietic Stem Cell Transplant in Patients with Dyskeratosis Congenita: Systematic Review of the Literature.

Authors:  Pasquale Barbaro; Aditi Vedi
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-08       Impact factor: 5.742

8.  Telomerase gene mutations are associated with cirrhosis formation.

Authors:  Daniel Hartmann; Ujala Srivastava; Michaela Thaler; Karin N Kleinhans; Gisèle N'kontchou; Annika Scheffold; Kerstin Bauer; Ramona F Kratzer; Natalia Kloos; Sarah-Fee Katz; Zhangfa Song; Yvonne Begus-Nahrmann; Alexander Kleger; Guido von Figura; Pavel Strnad; André Lechel; Cagatay Günes; Andrej Potthoff; Katja Deterding; Heiner Wedemeyer; Zhenyu Ju; Ge Song; Feng Xiao; Sonja Gillen; Hubert Schrezenmeier; Thomas Mertens; Marianne Ziol; Helmut Friess; Michael Jarek; Michael P Manns; Michel Beaugrand; K Lenhard Rudolph
Journal:  Hepatology       Date:  2011-05       Impact factor: 17.425

9.  Telomerase mutations in families with idiopathic pulmonary fibrosis.

Authors:  Mary Y Armanios; Julian J-L Chen; Joy D Cogan; Jonathan K Alder; Roxann G Ingersoll; Cheryl Markin; William E Lawson; Mingyi Xie; Irma Vulto; John A Phillips; Peter M Lansdorp; Carol W Greider; James E Loyd
Journal:  N Engl J Med       Date:  2007-03-29       Impact factor: 91.245

10.  Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis-emphysema.

Authors:  Susan E Stanley; Dustin L Gable; Christa L Wagner; Thomas M Carlile; Vidya Sagar Hanumanthu; Joshua D Podlevsky; Sara E Khalil; Amy E DeZern; Maria F Rojas-Duran; Carolyn D Applegate; Jonathan K Alder; Erin M Parry; Wendy V Gilbert; Mary Armanios
Journal:  Sci Transl Med       Date:  2016-08-10       Impact factor: 17.956

View more
  4 in total

Review 1.  Genetics of human telomere biology disorders.

Authors:  Patrick Revy; Caroline Kannengiesser; Alison A Bertuch
Journal:  Nat Rev Genet       Date:  2022-09-23       Impact factor: 59.581

2.  Disease progression and clinical outcomes in telomere biology disorders.

Authors:  Marena R Niewisch; Neelam Giri; Lisa J McReynolds; Rotana Alsaggaf; Sonia Bhala; Blanche P Alter; Sharon A Savage
Journal:  Blood       Date:  2022-03-24       Impact factor: 25.476

3.  Clinical and molecular correlates from a predominantly adult cohort of patients with short telomere lengths.

Authors:  Abhishek A Mangaonkar; Alejandro Ferrer; Filippo Pinto E Vairo; Caleb W Hammel; Carri Prochnow; Naseema Gangat; William J Hogan; Mark R Litzow; Steve G Peters; J P Scott; James P Utz; Misbah Baqir; Eva M Carmona-Porquera; Sanjay Kalra; Hiroshi Sekiguchi; Shakila P Khan; Douglas A Simonetto; Eric W Klee; Patrick S Kamath; Anja C Roden; Avni Y Joshi; Cassie C Kennedy; Mark E Wylam; Mrinal M Patnaik
Journal:  Blood Cancer J       Date:  2021-10-22       Impact factor: 11.037

Review 4.  Non-Melanoma Skin Cancers and Other Cutaneous Manifestations in Bone Marrow Failure Syndromes and Rare DNA Repair Disorders.

Authors:  Jennie Vagher; Amanda Gammon; Wendy Kohlmann; Joanne Jeter
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.